Hope Pharmaceuticals   Report issue

Contributed to NME For profit Phase 2 Phase 3
Founded: Scottsdale AZ United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2009
NCT00924118
First Marketed Drug
2011
sodium nitrite
First NDA Approval
2012
sodium nitrite
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hope Pharmaceuticals | HOPE PHARMS